ArticleFrontiers in medicine2025
Effect of a multicomponent intervention on institutionalization-free survival in older adults with sarcopenia: a
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sarcopenia: From Global Consensus to Korean Implementation - A Narrative Review and Standpoint.Annals of geriatric medicine and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the effect of a 24-week comprehensive multicomponent intervention on institutionalization-free survival, physical performance, and frailty among older adults with sarcopenia. Design: A post-hoc analysis of a prospective, non-randomized intervention study with 1:1 propensity score matching. Setting: Community-dwelling, socioeconomically vulnerable older adults. Participants: A total of 283 older adults with sarcopenia were included, with 145 in the intervention group and 138 in the control group. After propensity score matching, 102 pairs were analyzed. The mean age was 77.57 years (intervention) and 77.64 years (control), with 82.4 and 81.4% females in each group, respectively. Intervention: The multicomponent intervention consisted of exercise, nutritional support, depression management, deprescribing, and home hazard reduction, implemented over 24 weeks. Measurements: The primary outcome was 30-month institutionalization-free survival. Secondary outcomes included changes in physical performance (Short Physical Performance Battery [SPPB] scores, gait speed) and frailty index over 6, 18, and 30 months. Results: Following propensity score matching, mortality and institutionalization occurred in 13 (12.7%) and 35 (34.3%) participants in the intervention and control groups, respectively. A significant difference in 30-months institutionalization-free survival was observed between the intervention and control groups (63.4% vs. 87.2%). The intervention group had significantly higher SPPB scores and improved gait speed at 6 months, 18 months, and 30 months. The intervention group showed a significantly lower frailty index only at 6 months but similar scores at 18 and 30 months. Conclusion: The multicomponent intervention significantly improved long-term institutionalization-free survival and physical function in older adults with sarcopenia, highlighting its potential to enhance independence and reduce frailty in vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.